These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 31042551)

  • 1. Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined HF Population: The GENETIC-AF Trial.
    Piccini JP; Abraham WT; Dufton C; Carroll IA; Healey JS; van Veldhuisen DJ; Sauer WH; Anand IS; White M; Wilton SB; Aleong R; Rienstra M; Krueger SK; Ayala-Paredes F; Khaykin Y; Merkely B; Miloradović V; Wranicz JK; Ilkhanoff L; Ziegler PD; Davis G; Emery LL; Marshall D; Kao DP; Bristow MR; Connolly SJ;
    JACC Heart Fail; 2019 Jul; 7(7):586-598. PubMed ID: 31042551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genotype-directed comparative effectiveness trial of Bucindolol and metoprolol succinate for prevention of symptomatic atrial fibrillation/atrial flutter in patients with heart failure: Rationale and design of the GENETIC-AF trial.
    Piccini JP; Connolly SJ; Abraham WT; Healey JS; Steinberg BA; Al-Khalidi HR; Dignacco P; van Veldhuisen DJ; Sauer WH; White M; Wilton SB; Anand IS; Dufton C; Marshall DA; Aleong RG; Davis GW; Clark RL; Emery LL; Bristow MR
    Am Heart J; 2018 May; 199():51-58. PubMed ID: 29754666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics of Bucindolol in Atrial Fibrillation and Heart Failure.
    Parikh KS; Piccini JP
    Curr Heart Fail Rep; 2017 Dec; 14(6):529-535. PubMed ID: 28975475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bucindolol hydrochloride in atrial fibrillation and concomitant heart failure.
    Black-Maier E; Steinberg BA; Piccini JP
    Expert Rev Cardiovasc Ther; 2015 Jun; 13(6):627-36. PubMed ID: 25959096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose Response of β-Blockers in Adrenergic Receptor Polymorphism Genotypes.
    Parikh KS; Fiuzat M; Davis G; Neely M; Blain-Nelson P; Whellan DJ; Abraham WT; Adams KF; Felker GM; Liggett SB; O'Connor CM; Bristow MR
    Circ Genom Precis Med; 2018 Aug; 11(8):e002210. PubMed ID: 30354340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation.
    Kao DP; Davis G; Aleong R; O'Connor CM; Fiuzat M; Carson PE; Anand IS; Plehn JF; Gottlieb SS; Silver MA; Lindenfeld J; Miller AB; White M; Murphy GA; Sauer W; Bristow MR
    Eur J Heart Fail; 2013 Mar; 15(3):324-33. PubMed ID: 23223178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of atrial fibrillation by bucindolol is dependent on the beta₁389 Arg/Gly adrenergic receptor polymorphism.
    Aleong RG; Sauer WH; Davis G; Murphy GA; Port JD; Anand IS; Fiuzat M; O'Connor CM; Abraham WT; Liggett SB; Bristow MR
    JACC Heart Fail; 2013 Aug; 1(4):338-344. PubMed ID: 24159564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic drug evaluation of bucindolol for the treatment of atrial fibrillation in heart failure patients.
    Rosa GM; Meliota G; Brunelli C; Ferrero S
    Expert Opin Drug Metab Toxicol; 2017 Apr; 13(4):473-481. PubMed ID: 28162002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bucindolol Decreases Atrial Fibrillation Burden in Patients With Heart Failure and the
    Piccini JP; Dufton C; Carroll IA; Healey JS; Abraham WT; Khaykin Y; Aleong R; Krueger SK; Sauer WH; Wilton SB; Rienstra M; van Veldhuisen DJ; Anand IS; White M; Camm AJ; Ziegler PD; Marshall D; Bristow MR; Connolly SJ;
    Circ Arrhythm Electrophysiol; 2021 Aug; 14(8):e009591. PubMed ID: 34270905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol.
    Sehnert AJ; Daniels SE; Elashoff M; Wingrove JA; Burrow CR; Horne B; Muhlestein JB; Donahue M; Liggett SB; Anderson JL; Kraus WE
    J Am Coll Cardiol; 2008 Aug; 52(8):644-51. PubMed ID: 18702968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of benefit and early hazard of bucindolol for Class IV heart failure.
    Anderson JL; Krause-Steinrauf H; Goldman S; Clemson BS; Domanski MJ; Hager WD; Murray DR; Mann DL; Massie BM; McNamara DM; Oren R; Rogers WJ;
    J Card Fail; 2003 Aug; 9(4):266-77. PubMed ID: 13680547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: findings from the EVEREST Trial.
    Mentz RJ; Chung MJ; Gheorghiade M; Pang PS; Kwasny MJ; Ambrosy AP; Vaduganathan M; O'Connor CM; Swedberg K; Zannad F; Konstam MA; Maggioni AP
    Am Heart J; 2012 Dec; 164(6):884-92.e2. PubMed ID: 23194489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenergic receptor polymorphisms and prevention of ventricular arrhythmias with bucindolol in patients with chronic heart failure.
    Aleong RG; Sauer WH; Robertson AD; Liggett SB; Bristow MR
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):137-43. PubMed ID: 23275278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blockers and outcome in heart failure and atrial fibrillation: a meta-analysis.
    Rienstra M; Damman K; Mulder BA; Van Gelder IC; McMurray JJ; Van Veldhuisen DJ
    JACC Heart Fail; 2013 Feb; 1(1):21-8. PubMed ID: 24621795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
    Slee A; Saad M; Saksena S
    J Interv Card Electrophysiol; 2019 Sep; 55(3):325-331. PubMed ID: 30887281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is beta-blockade useful in heart failure patients with atrial fibrillation? An analysis of data from two previously completed prospective trials.
    Fung JW; Chan SK; Yeung LY; Sanderson JE
    Eur J Heart Fail; 2002 Aug; 4(4):489-94. PubMed ID: 12167389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation.
    Ahn MS; Yoo BS; Son JW; Yu MH; Kang DR; Lee HY; Jeon ES; Kim JJ; Chae SC; Baek SH; Kang SM; Choi DJ; Kim KH; Cho MC; Kim SY
    J Korean Med Sci; 2020 Aug; 35(33):e278. PubMed ID: 32830467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
    Lobmeyer MT; Gong Y; Terra SG; Beitelshees AL; Langaee TY; Pauly DF; Schofield RS; Hamilton KK; Herbert Patterson J; Adams KF; Hill JA; Aranda JM; Johnson JA
    Pharmacogenet Genomics; 2007 Apr; 17(4):277-82. PubMed ID: 17496726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased Mortality With Beta-Blockers in Patients With Heart Failure and Coexisting Atrial Fibrillation: An AF-CHF Substudy.
    Cadrin-Tourigny J; Shohoudi A; Roy D; Talajic M; Tadros R; Mondésert B; Dyrda K; Rivard L; Andrade JG; Macle L; Guerra PG; Thibault B; Dubuc M; Khairy P
    JACC Heart Fail; 2017 Feb; 5(2):99-106. PubMed ID: 28089316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of treatment with carvedilol vs metoprolol succinate and mortality in patients with heart failure.
    Pasternak B; Svanström H; Melbye M; Hviid A
    JAMA Intern Med; 2014 Oct; 174(10):1597-604. PubMed ID: 25173681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.